| UniProt ID | TNIP2_HUMAN | |
|---|---|---|
| UniProt AC | Q8NFZ5 | |
| Protein Name | TNFAIP3-interacting protein 2 | |
| Gene Name | TNIP2 {ECO:0000312|EMBL:EAW82514.1} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 429 | |
| Subcellular Localization | Cytoplasm . Nucleus . | |
| Protein Description | Inhibits NF-kappa-B activation by blocking the interaction of RIPK1 with its downstream effector NEMO/IKBKG. Forms a ternary complex with NFKB1 and MAP3K8 but appears to function upstream of MAP3K8 in the TLR4 signaling pathway that regulates MAP3K8 activation. Involved in activation of the MEK/ERK signaling pathway during innate immune response; this function seems to be stimulus- and cell type specific. Required for stability of MAP3K8. Involved in regulation of apoptosis in endothelial cells; promotes TEK agonist-stimulated endothelial survival. May act as transcriptional coactivator when translocated to the nucleus. Enhances CHUK-mediated NF-kappa-B activation involving NF-kappa-B p50-p65 and p50-c-Rel complexes.. | |
| Protein Sequence | MSRDPGSGGWEEAPRAAAALCTLYHEAGQRLRRLQDQLAARDALIARLRARLAALEGDAAPSLVDALLEQVARFREQLRRQEGGAAEAQMRQEIERLTERLEEKEREMQQLLSQPQHEREKEVVLLRRSMAEGERARAASDVLCRSLANETHQLRRTLTATAHMCQHLAKCLDERQHAQRNVGERSPDQSEHTDGHTSVQSVIEKLQEENRLLKQKVTHVEDLNAKWQRYNASRDEYVRGLHAQLRGLQIPHEPELMRKEISRLNRQLEEKINDCAEVKQELAASRTARDAALERVQMLEQQILAYKDDFMSERADRERAQSRIQELEEKVASLLHQVSWRQDSREPDAGRIHAGSKTAKYLAADALELMVPGGWRPGTGSQQPEPPAEGGHPGAAQRGQGDLQCPHCLQCFSDEQGEELLRHVAECCQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSRDPGSGG ------CCCCCCCCC | 45.45 | - | |
| 7 | Phosphorylation | -MSRDPGSGGWEEAP -CCCCCCCCCCCHHH | 39.25 | 23401153 | |
| 22 | Phosphorylation | RAAAALCTLYHEAGQ HHHHHHHHHHHHHHH | 31.07 | 21712546 | |
| 24 | Phosphorylation | AAALCTLYHEAGQRL HHHHHHHHHHHHHHH | 4.58 | 21712546 | |
| 62 | Phosphorylation | LEGDAAPSLVDALLE HHCCCCHHHHHHHHH | 35.98 | 30108239 | |
| 113 | Phosphorylation | REMQQLLSQPQHERE HHHHHHHCCCHHHHH | 48.70 | 24043423 | |
| 121 | Ubiquitination | QPQHEREKEVVLLRR CCHHHHHHHHHHHHH | 63.13 | - | |
| 129 | Phosphorylation | EVVLLRRSMAEGERA HHHHHHHHHHHHHHH | 18.86 | - | |
| 140 | Phosphorylation | GERARAASDVLCRSL HHHHHHHHHHHHHHH | 27.54 | 27251275 | |
| 146 | Phosphorylation | ASDVLCRSLANETHQ HHHHHHHHHHHHHHH | 30.73 | 30108239 | |
| 170 | Ubiquitination | HMCQHLAKCLDERQH HHHHHHHHHHHHHHH | 41.51 | - | |
| 186 | Phosphorylation | QRNVGERSPDQSEHT HHCCCCCCCCCCCCC | 28.64 | 23401153 | |
| 190 | Phosphorylation | GERSPDQSEHTDGHT CCCCCCCCCCCCCCC | 38.43 | 23663014 | |
| 193 | Phosphorylation | SPDQSEHTDGHTSVQ CCCCCCCCCCCCHHH | 39.36 | 23663014 | |
| 197 | Phosphorylation | SEHTDGHTSVQSVIE CCCCCCCCHHHHHHH | 35.80 | 29255136 | |
| 198 | Phosphorylation | EHTDGHTSVQSVIEK CCCCCCCHHHHHHHH | 16.69 | 29255136 | |
| 201 | Phosphorylation | DGHTSVQSVIEKLQE CCCCHHHHHHHHHHH | 23.94 | 29255136 | |
| 205 | Ubiquitination | SVQSVIEKLQEENRL HHHHHHHHHHHHCHH | 44.33 | - | |
| 279 | Ubiquitination | INDCAEVKQELAASR HHHHHHHHHHHHHHH | 29.56 | - | |
| 330 | Ubiquitination | RIQELEEKVASLLHQ HHHHHHHHHHHHHHH | 33.45 | - | |
| 333 | Phosphorylation | ELEEKVASLLHQVSW HHHHHHHHHHHHHHC | 34.16 | 30108239 | |
| 339 | Phosphorylation | ASLLHQVSWRQDSRE HHHHHHHHCCCCCCC | 15.24 | 27273156 | |
| 344 | Phosphorylation | QVSWRQDSREPDAGR HHHCCCCCCCCCCCC | 30.15 | 26699800 | |
| 356 | Phosphorylation | AGRIHAGSKTAKYLA CCCCCCCHHHHHHHH | 27.84 | 27273156 | |
| 357 | Ubiquitination | GRIHAGSKTAKYLAA CCCCCCHHHHHHHHH | 52.14 | - | |
| 361 | Phosphorylation | AGSKTAKYLAADALE CCHHHHHHHHHHHHH | 10.10 | 27642862 | |
| 413 | Phosphorylation | PHCLQCFSDEQGEEL CCHHHHCCHHHHHHH | 48.11 | 30108239 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNIP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNIP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TNAP3_HUMAN | TNFAIP3 | physical | 21266526 | |
| M3K8_HUMAN | MAP3K8 | physical | 15169888 | |
| NFKB1_HUMAN | NFKB1 | physical | 15169888 | |
| NEMO_HUMAN | IKBKG | physical | 14653779 | |
| IKKA_HUMAN | CHUK | physical | 21784860 | |
| IKKB_HUMAN | IKBKB | physical | 21784860 | |
| SMRD1_HUMAN | SMARCD1 | physical | 12753905 | |
| TIE2_HUMAN | TEK | physical | 12609966 | |
| STK11_HUMAN | STK11 | physical | 12595760 | |
| A4_HUMAN | APP | physical | 21832049 | |
| UBC_HUMAN | UBC | physical | 19373254 | |
| UBC_HUMAN | UBC | physical | 27916521 | |
| UBP35_HUMAN | USP35 | physical | 26348204 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY. | |